Skip to main content

Neuroendocrine Tumors

Neuroendocrine Year in Review Introduction

CLARINET FORTE Study Results of Lanreotide Autogel in Progressive Pancreatic or Midgut NETs

Avelumab in Unresectable/Metastatic, Progressive Neuroendocrine Neoplasms

Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms

Phase 2 NICE-NEC Study of First-Line Platinum-Doublet Chemotherapy + Nivolumab in Unresectable Locally Advanced or Metastatic Grade 3 NENs

Irinotecan + Cisplatin versus Etoposide + Cisplatin for High-Grade Neuroendocrine Carcinoma of the Lung

Temozolomide Alone or Combined with Capecitabine in Metastatic Neuroendocrine Neoplasia

Toxicity Profile of Capecitabine/Temozolomide in NETs

Cabozantinib in High-Grade Neuroendocrine Neoplasms

Efficacy of FOLFOX with or without Bevacizumab in Patients with Aggressive Pancreatic NETs

1
2
3
4

Page 1 of 4
Results 1 - 10 of 31